Published • loading... • Updated
The HIV shot that could change medicine is facing its biggest test: Getting to patients
Summary by Business Insider
1 Articles
1 Articles
The HIV shot that could change medicine is facing its biggest test: Getting to patients
Trials of lenacapavir, a drug developed by Gilead Sciences, show the twice-a-year shot is almost 100% effective at preventing HIV infection.Ihsaan Haffejee / AFP via Getty ImagesGilead's lenacapavir shows near 100% efficacy in preventing HIV with twice-yearly shots, reports The Telegraph.Some Latin American countries face barriers to accessing lenacapavir despite running crucial trials.Beyond price, supply is constrained as Gilead works to scale…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
